Single nucleotide polymorphisms (SNPs) and circulating endothelial cells (CECs) as outcome predictors in recurrent glioblastoma (rGBM) patients (pts) treated with bevacizumab (BEV) and sorafenib (SOR).
- Citation:
- J Clin Oncol vol 29 (15s) abstr 2019
- Meeting Instance:
- ASCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Parents:
- None
- Children:
- 1040
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. K. Anderson J. M. Lafky X. W. Carrero T. K. Kimlinger T. M. Halling S. Kumar P. J. Flynn H. M. Gross K. A. Jaeckle J. C. Buckner
- Networks:
- Study
- NCCTG-N0776
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: